IONIQ Science 2022 year-end update

For IONIQ Sciences, 2022 was another big year. As we respond to the FDA’s substantive review of our De Novo application for the ‘breakthrough‘ IONIQ ProLung Test, powerful macroeconomic factors are highlighting the importance of early cancer detection. Despite uncertain conditions in the financial market, we have a compelling message for potential institutional and strategic investors at […]

Read More

2022 BIO Report Ranks Utah in the Top Eight States for Bioscience Specialization

The 2022 TEConomy/BIO report, The US Bioscience Industry: Fostering Innovation and Driving America’s Economy Forward, examines the bioscience industry’s impact on the national economy and provides state specific data, with Utah and its major metropolitan areas ranking high in specialized employment concentration in three major subsectors – medical device manufacturing, pharmaceuticals, research, testing and medical laboratories […]

Read More